Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: A population-based case-control study in Shanghai, China

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 944-948

  Chang, Shih Chen ^a   Rashid, Asif ^b   Gao, Yu tang ^c   Andreotti, Gabriella ^a   Shen, Ming Chang ^d   Wang, Bin Sheng ^e   Han, Tian Quan ^f   Zhang, Bai He ^g   Sakoda, Lori C ^a   Leitzmann, Michael F ^a   Chen, Bingshu E ^a   Rosenberg, Philip S ^a   Chen, Jinbo ^h   Chanock, Stephen J ^a,i   Hsing, Ann W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d Shanghai Tumor Institute   (China)

^e ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^g Oriental Hepato biliary Surgery Hospital   (China)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BILE DUCT STONE; BILIARY TRACT CANCER; BODY MASS; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VATER PAPILLA CARCINOMA;

ADULT; AGED; BILE DUCT NEOPLASMS; CASE-CONTROL STUDIES; CHINA; DNA, NEOPLASM; FEMALE; GALLBLADDER NEOPLASMS; GALLSTONES; HUMANS; INCIDENCE; INSULIN; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PPAR GAMMA; RECEPTORS, RETINOIC ACID; RISK FACTORS;

EID: 47249092818     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn025     Document Type: Article

References (37)

1. Hsing,A.W. et al. (2005) Biliary tract cancer. In: Schottenfeld,D., Fraumeni,J.F.Jr (eds.) Cancer Epidemiology and Prevention. Oxford University Press, New York, NY, pp. 787-800.
2. Hsing,A.W. et al. (1998) Rising incidence of biliary tract cancers in Shanghai, China. Int. J. Cancer, 75, 368-370.
3. Tominaga,S. et al. (1994) Biliary tract cancer. Cancer Surv. 19-20, 125-137.
4. Rai,A. et al. (2004) A review of association of dietary factors in gallbladder cancer. Indian J. Cancer, 41, 147-151.
5. De Santis,A. et al. (1997) Gallstones and diabetes: A case-control study in a free-living population sample. Hepatology, 25, 787-790.
6. Barbara,L. et al. (1987) A population study on the prevalence of gallstone disease: The Sirmione study. Hepatology, 7, 913-917.
7. Chow,W.H. et al. (1995) Smoking and biliary tract cancers in a cohort of US veterans. Br. J. Cancer, 72, 1556-1558.
8. Kato,I. et al. (1992) Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites. Cancer Causes Control, 3, 145-151.
9. Moerman,C.J. et al. (1994) Reproductive history and cancer of the biliary tract in women. Int. J. Cancer, 57, 146-153.
10. Garfinkel,L. (1986) Overweight and mortality. Cancer, 58, 1826-1829.
11. Zatonski,W.A. et al. (1992) Risk factors for gallbladder cancer: A Polish case-control study. Int. J. Cancer, 51, 707-711.
12. Chow,W.H. et al. (1994) Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 5, 267-272.
13. Yamauchi,T. et al. (2001) Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest., 108, 1001-1013.
14. Lee,C.H. et al. (2006) PPARI {delta} regulates glucose metabolism and insulin sensitivity. Proc. Natl. Acad. Sci. USA, 103, 3444-3449.
15. Moller,D.E. et al. (2003) Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int. J. Obes. Relat. Metab. Disord., 27, S17-S21.
16. Dubuquoy,L. et al. (2002) Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastmenterological diseases. Lancet, 360 1410-1418.
17. Hu,C. et al. (2006) Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabet. Med., 12, 1307-1312.
18. Vidal-Puig,A.J. et al. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticolds. J. Clin. Invest. 99, 2416-2422.
19. Gong,Z. et al. (2005) The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis, 26, 579-585.
20. Jiang,J. et al. (2005) Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. Cancer Sci., 96, 507-512.
21. Nohara,A. et al. (2007) "High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol., 27, 923-928.
22. Obara,W. et al. (2007) Elimination of lipid peroxide during hemodialysis. Nephron Clin. Pract., 106, 162-168.
23. Ho,G.Y. et al. (2003) Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br. J. Cancer, 88, 263-269.
24. Sakoda,L.C. et al. (2006) Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: A population-based study in Shanghai, China. Carcinogenesis, 27, 1251-1256.
25. Zhang,X.H. et al. (2006) Tea drinking and the risk of biliary tract cancers and biliary stones: A population-based case-control study in Shanghai, China. Int. J. Cancer, 118, 3089-3094.
26. Liu,E. et al. (2005) Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., 14, 1315-1318.
27. Packer,B.R. et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34 D617-D621.
28. Simes,R.J. (1986) An improved Bonferroni procedure for multiple tests of significance. Biometrika, 73, 751-754.
29. Wacholder,S. et al. (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.
30. Haffner,S.M. et al. (1990) Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am. J. Epidemiol., 132, 327-335.
31. Laakso,M. et al. (1990) Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: A case control study. Gut, 31, 344-347.
32. Scragg,R.K. et al. (1984) Plasma lipids and insulin in gall stone disease: A case-control study. Br. Med. J., 289, 521-525.
33. Ruhl,C.E. et al. (2000) Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology, 31, 299-303.
34. Misciagna,G. et al. (2000) Insulin and gall stones: A population case control study in southern Italy. Gut, 47, 144-147.
35. Nervi,F. et al. (2006) Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J. Hepatol. 45, 299-305.
36. Fitzgibbon,J. et al. (1993) Mapping of RXRB to human chromosome 6p21.3. Ann. Hum. Genet., 57, 203-209.
37. Rajsbaum,R. et al. (2001) Polymorphism of the human retinoid X receptor beta and linkage disequilibrium with HLA-DPB1. Tissue Antigens, 58, 24-29.